Literature DB >> 2455730

In vitro T-cell functions specific to an anti-DNA idiotype and serological markers in patients with systemic lupus erythematosus (SLE).

S Mendlovic1, Y Shoenfeld, R Bakimer, R Segal, M Dayan, E Mozes.   

Abstract

The human monoclonal autoantibody 16/6 is a common anti-DNA idiotype found to have clinical relevance in patients with systemic lupus erythematosus (SLE). Therefore the ability of peripheral blood T cells of SLE patients and healthy controls to proliferate and to produce helper T-cell factors following stimulation with this idiotype was tested. It was found that T cells of 75% of healthy donors proliferated to the 16/6 idiotype, whereas only 22% of SLE patients responded to this idiotype by proliferation. On the other hand, the capability to produce T-cell helper factors specific to the 16/6 idiotype was found in a higher percentage of SLE patients (48%) as compared to healthy controls (31%). The low frequency of proliferative responses in SLE patients might be due either to the chronic exposure to the 16/6 idiotype or to the production of antiidiotype antibodies against the 16/6 idiotype, which interfere with the response to the latter stimulator.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455730     DOI: 10.1007/bf00917564

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  25 in total

Review 1.  The idiotype-antiidiotype network in human autoimmunity.

Authors:  N I Abdou
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

2.  Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen.

Authors:  A B Gottlieb; R G Lahita; N Chiorazzi; H G Kunkel
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

3.  Influenza immunization in systemic lupus eruthematosus. A double-blind trial.

Authors:  G W Williams; A D Steinberg; J L Reinertsen; L W Klassen; J L Decker; R Dolin
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

4.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

5.  Production of autoantibodies by human-human hybridomas.

Authors:  Y Shoenfeld; S C Hsu-Lin; J E Gabriels; L E Silberstein; B C Furie; B Furie; B D Stollar; R S Schwartz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

6.  Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

7.  Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus.

Authors:  D A Isenberg; Y Shoenfeld; R S Schwartz
Journal:  Arthritis Rheum       Date:  1984-02

8.  Detection of cross reactive anti-DNA antibody idiotypes on tissue-bound immunoglobulins from skin biopsies of lupus patients.

Authors:  D Isenberg; C Dudeney; F Wojnaruska; B S Bhogal; J Rauch; A Schattner; Y Naparstek; D Duggan
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

9.  In vitro production of an anti-DNA idiotype by lymphocytes of normal subjects and patients with systemic lupus erythematosus.

Authors:  S K Datta; Y Naparstek; R S Schwartz
Journal:  Clin Immunol Immunopathol       Date:  1986-03

10.  Idiotypic cross-reactions of monoclonal human lupus autoantibodies.

Authors:  Y Shoenfeld; D A Isenberg; J Rauch; M P Madaio; B D Stollar; R S Schwartz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  6 in total

1.  Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.

Authors:  M Dayan; R Segal; Z Sthoeger; A Waisman; N Brosh; O Elkayam; E Eilat; M Fridkin; E Mozes
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

2.  Anti-DNA idiotype- and anti-idiotype-specific T cell responses in patients with systemic lupus erythematosus and their first-degree relatives.

Authors:  S Mendlovic; R Segal; Y Shoenfeld; E Mozes
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Anti-idiotype and immunosuppressant treatment of murine lupus.

Authors:  C Morland; J Michael; D Adu; T Kizaki; A J Howie; A Morgan; N A Staines
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

4.  Modulation of autoreactive responses of peripheral blood lymphocytes of patients with systemic lupus erythematosus by peptides based on human and murine anti-DNA autoantibodies.

Authors:  Z M Sthoeger; M Dayan; A Tcherniack; L Green; S Toledo; R Segal; O Elkayam; E Mozes
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 5.  Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides-As Antigens for Th Cells.

Authors:  Kristin Aas-Hanssen; Keith M Thompson; Bjarne Bogen; Ludvig A Munthe
Journal:  Front Immunol       Date:  2015-07-28       Impact factor: 7.561

Review 6.  Triggers of Autoimmunity: The Role of Bacterial Infections in the Extracellular Exposure of Lupus Nuclear Autoantigens.

Authors:  Connie C Qiu; Roberto Caricchio; Stefania Gallucci
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.